Log in

OTCMKTS:LXRPLexaria Bioscience Stock Price, Forecast & News

+0.01 (+2.88 %)
(As of 04/9/2020 03:37 AM ET)
Today's Range
Now: $0.30
50-Day Range
MA: $0.35
52-Week Range
Now: $0.30
Volume161,794 shs
Average Volume112,771 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
Lexaria Bioscience Corp. engages in the development of strategic partnerships and in the proprietary nutrient infusion technologies for the production of superfoods. It operates through the IP Licensing and Consumer Products segments. The company was founded on December 9, 2004 and is headquartered in Kelowna, Canada.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.3Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.46 out of 5 stars

Industry, Sector and Symbol

Industry Packaged Foods
SectorConsumer Defensive
Current SymbolOTCMKTS:LXRP
Phone(250) 765-6424



Sales & Book Value

Annual SalesN/A



Next Earnings DateN/A
OptionableNot Optionable

Receive LXRP News and Ratings via Email

Sign-up to receive the latest news and ratings for LXRP and its competitors with MarketBeat's FREE daily newsletter.

Lexaria Bioscience (OTCMKTS:LXRP) Frequently Asked Questions

How has Lexaria Bioscience's stock been impacted by COVID-19 (Coronavirus)?

Lexaria Bioscience's stock was trading at $0.3101 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, LXRP shares have decreased by 3.3% and is now trading at $0.30. View which stocks have been most impacted by Coronavirus.

Has Lexaria Bioscience been receiving favorable news coverage?

News coverage about LXRP stock has trended very negative on Thursday, InfoTrie Sentiment reports. The research group ranks the sentiment of news coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. Lexaria Bioscience earned a media sentiment score of -3.3 on InfoTrie's scale. They also gave headlines about the oil and gas exploration company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the company's share price in the near term. View the latest news aboutLexaria Bioscience.

Who are some of Lexaria Bioscience's key competitors?

What other stocks do shareholders of Lexaria Bioscience own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Lexaria Bioscience investors own include Canopy Growth (CGC), Cronos Group (CRON), Aurora Cannabis (ACBFF), OrganiGram (OGI), CV Sciences (CVSI), Aphria (APHQF), InMed Pharmaceuticals (IMLFF), GW Pharmaceuticals PLC- (GWPH), Alibaba Group (BABA) and 22nd Century Group (XXII).

Who are Lexaria Bioscience's key executives?

Lexaria Bioscience's management team includes the following people:
  • Christopher A. Bunka, Chairman & Chief Executive Officer
  • John Martin Docherty, President & Director
  • Allan Spissinger, Chief Financial Officer, Secretary & Treasurer
  • Alex Blanchard, Manager-Investor Relations & Communications
  • Ed Ergenzinger, Chief Legal Officer & Senior VP-Innovation

What is Lexaria Bioscience's stock symbol?

Lexaria Bioscience trades on the OTCMKTS under the ticker symbol "LXRP."

How do I buy shares of Lexaria Bioscience?

Shares of LXRP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Lexaria Bioscience's stock price today?

One share of LXRP stock can currently be purchased for approximately $0.30.

What is Lexaria Bioscience's official website?

The official website for Lexaria Bioscience is http://www.lexariaenergy.com/.

How can I contact Lexaria Bioscience?

Lexaria Bioscience's mailing address is 156 Valleyview Rd, KELOWNA, BC V1X 3M4, Canada. The oil and gas exploration company can be reached via phone at (250) 765-6424.

This page was last updated on 4/9/2020 by MarketBeat.com Staff

Featured Article: How Short Selling Works

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel